Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca Pulls Twitter Ads, Showing Risks Of Expansive Social Media Platforms

Aug 30 2013

• By Sarah Karlin-Smith

Related Content

DDMAC Dislike: FDA Cracks Down On Facebook Widget Used On Tasigna Website

Aug 05 2010

Keywords Not Major Advertising Enforcement Concern, FDA Says

Aug 23 2013

Rx Firms Still Bear Promotional Compliance Burden If Social Media Platform Changes, FDA Says

Jun 27 2013

Internet Promotions Must Be Redesigned After FDA Cites Sponsored Web Links

Apr 13 2009

FDA’s Biggest DTC Advertising Study Eyes Online Promotion

Jul 08 2013

Related Companies

AstraZeneca PLC

Novartis AG

Additional Topics

United States Regulation Post Market Regulation & Studies Advertising, Marketing & Sales BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window